Liquid Biopsy – New hope for cancer care as new test facilitates mutation detection.
In a development that could transform the management of cancer patients, an Indian laboratory has claimed to have cracked the difficulties related to tracing malignant cells and avoid repeated biopsies.
Doctors often are forced to conduct repeated biopsy tests to detect certain types of cancers related to skin, lung and colon.
But with the new method — liquid biopsy test — developed for the first time in India, physicians can identify genetic alterations, interpret, assess and treat various forms of cancer, the company said.
The test has also been validated in a scientific study and facilitates detection of mutation where there is difficulty of obtaining biopsy or in the event of a damaged biopsy material and non-availability of tissue biopsy.